Free Trial

ZimVie (ZIMV) Competitors

ZimVie logo
$9.36 -0.02 (-0.27%)
As of 03:02 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ZIMV vs. INMD, BLFS, MDXG, AORT, EYE, ESTA, AXGN, EMBC, IRMD, and BVS

Should you be buying ZimVie stock or one of its competitors? The main competitors of ZimVie include InMode (INMD), BioLife Solutions (BLFS), MiMedx Group (MDXG), Artivion (AORT), National Vision (EYE), Establishment Labs (ESTA), AxoGen (AXGN), Embecta (EMBC), Iradimed (IRMD), and Bioventus (BVS). These companies are all part of the "medical equipment" industry.

ZimVie vs.

ZimVie (NASDAQ:ZIMV) and InMode (NASDAQ:INMD) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, community ranking, risk and valuation.

InMode has a net margin of 45.91% compared to ZimVie's net margin of -77.31%. InMode's return on equity of 18.25% beat ZimVie's return on equity.

Company Net Margins Return on Equity Return on Assets
ZimVie-77.31% 2.90% 1.17%
InMode 45.91%18.25%16.33%

ZimVie currently has a consensus target price of $19.50, suggesting a potential upside of 107.89%. InMode has a consensus target price of $21.25, suggesting a potential upside of 36.39%. Given ZimVie's stronger consensus rating and higher probable upside, research analysts plainly believe ZimVie is more favorable than InMode.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ZimVie
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
3.00
InMode
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40

ZimVie has a beta of 2.14, indicating that its share price is 114% more volatile than the S&P 500. Comparatively, InMode has a beta of 1.96, indicating that its share price is 96% more volatile than the S&P 500.

In the previous week, ZimVie had 5 more articles in the media than InMode. MarketBeat recorded 7 mentions for ZimVie and 2 mentions for InMode. ZimVie's average media sentiment score of 1.15 beat InMode's score of 0.21 indicating that ZimVie is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ZimVie
5 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
InMode
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

InMode received 156 more outperform votes than ZimVie when rated by MarketBeat users. Likewise, 72.97% of users gave InMode an outperform vote while only 28.57% of users gave ZimVie an outperform vote.

CompanyUnderperformOutperform
ZimVieOutperform Votes
6
28.57%
Underperform Votes
15
71.43%
InModeOutperform Votes
162
72.97%
Underperform Votes
60
27.03%

95.6% of ZimVie shares are held by institutional investors. Comparatively, 68.0% of InMode shares are held by institutional investors. 3.0% of ZimVie shares are held by insiders. Comparatively, 6.9% of InMode shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

InMode has lower revenue, but higher earnings than ZimVie. ZimVie is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ZimVie$449.75M0.58-$393.28M-$0.95-9.87
InMode$394.82M2.74$181.27M$2.356.63

Summary

InMode beats ZimVie on 11 of the 19 factors compared between the two stocks.

Get ZimVie News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZIMV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZIMV vs. The Competition

MetricZimVieDental equipment & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$261.21M$3.56B$5.35B$7.51B
Dividend YieldN/A2.66%5.44%4.33%
P/E Ratio-0.7239.4821.9618.05
Price / Sales0.581.28396.51104.31
Price / Cash2.776.5738.2034.62
Price / Book0.610.606.734.14
Net Income-$393.28M-$146.24M$3.21B$247.59M
7 Day Performance-0.11%4.42%3.97%3.51%
1 Month Performance-18.36%-12.26%-7.03%-5.80%
1 Year Performance-40.67%-30.67%15.46%2.83%

ZimVie Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZIMV
ZimVie
2.5844 of 5 stars
$9.35
-0.3%
$19.50
+108.5%
-41.6%$260.37M$449.75M-0.712,700Positive News
INMD
InMode
2.0042 of 5 stars
$15.08
+1.3%
$21.25
+40.9%
-10.3%$1.05B$394.82M6.42480Upcoming Earnings
BLFS
BioLife Solutions
2.1852 of 5 stars
$22.08
+0.8%
$31.17
+41.2%
+43.1%$1.04B$82.25M-20.83440Positive News
MDXG
MiMedx Group
3.1016 of 5 stars
$6.77
-1.0%
$12.00
+77.3%
+4.1%$997.67M$348.88M12.31870Upcoming Earnings
AORT
Artivion
2.9041 of 5 stars
$23.15
-0.9%
$31.40
+35.6%
+14.4%$997.64M$388.54M-1,157.501,300News Coverage
Positive News
EYE
National Vision
1.8708 of 5 stars
$11.84
+2.6%
$14.00
+18.2%
-37.6%$932.79M$1.82B-59.2014,000Positive News
ESTA
Establishment Labs
2.19 of 5 stars
$31.32
+3.2%
$57.40
+83.3%
-40.1%$903.46M$166.03M-12.14960
AXGN
AxoGen
2.8121 of 5 stars
$16.06
+1.1%
$22.60
+40.7%
+124.1%$712.17M$187.34M-50.19450Upcoming Earnings
Positive News
EMBC
Embecta
4.5577 of 5 stars
$11.90
-3.3%
$20.33
+70.9%
+3.3%$691.80M$1.11B11.901,900Positive News
IRMD
Iradimed
4.9006 of 5 stars
$53.03
+1.4%
$72.00
+35.8%
+25.8%$674.28M$73.24M35.35110Upcoming Earnings
News Coverage
Positive News
Gap Down
BVS
Bioventus
3.2032 of 5 stars
$7.92
+5.9%
$15.00
+89.4%
+76.1%$612.94M$573.28M-12.981,200Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:ZIMV) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners